Flow cytometric DNA analysis and chromosomal aberrations in malignant glioblastomas

被引:31
|
作者
Ehemann, V
Hashemi, B
Lange, A
Otto, HF
机构
[1] Univ Heidelberg, Inst Pathol, D-69120 Heidelberg, Germany
[2] Univ Heidelberg, Dept Neurosurg, D-69120 Heidelberg, Germany
关键词
glioblastoma; cytogenetics; flow cytometry; DNA index; cell cycle; FISH;
D O I
10.1016/S0304-3835(98)00383-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study we combined flow cytometry with fluorescence in situ hybridization to detect numerical aberrations in chromosomes. Fifty-nine human malignant gliomas were examined by flow cytometry for DNA-content and cell cycle analysis and for numerical aberrations of chromosome 1 by in situ hybridization using a chromosome specific centromere probe. Of the gliomas analysed, 42% were diploid and 58% showed aneuploid tumour cell populations. The DNA index was heterogeneous ranging from 1.0 to 2.3. The S-phase analysis showed proliferation activity from a very low range of 0.7% up to 17.0%. In general, diploid gliomas exhibited a lower S-phase activity than aneuploid gliomas. Of the aneuploid gliomas, 15% showed a peridiploid pattern with a DNA index mean of 1.1. In these peridiploid rumours a trisomy of chromosome I could be detected by fluorescence in situ hybridization (FISH). The frequency of trisomic chromosome 1 in malignant gliomas reflects a very slight increase in DNA index from diploid to peridiploid (DNA index 1.1). Comparison of chromosome numbers and DNA content gave good correlation. Also important, the results reflects the cell cycle, specifically the extent of S-phase activity. In general, cell proliferation of diploid and peridiploid gliomas is much less than in higher aneuploid gliomas. The analysis of DNA content may thus yield results with respect to the biological behaviour of tumours in general. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:101 / 106
页数:6
相关论文
共 50 条
  • [1] DNA FLOW CYTOMETRIC ANALYSIS OF HEMANGIOPERICYTOMA
    FINN, WG
    GOOLSBY, CL
    SAMBASIVA, M
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 101 (02) : 181 - 185
  • [2] FLOW CYTOMETRIC ANALYSIS OF THE DNA CONTENT OF THYMOMAS
    KUSHIBE, K
    IIOKA, S
    NEZU, K
    TOJO, T
    SAWABATA, N
    KITAMURA, S
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1995, 25 (04): : 334 - 337
  • [3] Prognostic significance of flow cytometric DNA analysis in patients with malignant pleural mesothelioma
    Emri, S
    Akbulut, H
    Zorlu, F
    Dinçol, D
    Akay, H
    Güngen, Y
    Içli, F
    LUNG CANCER, 2001, 33 (2-3) : 109 - 114
  • [4] DNA FLOW CYTOMETRIC ANALYSIS OF SEROUS OVARIAN-TUMORS OF LOW MALIGNANT POTENTIAL
    SEIDMAN, JD
    NORRIS, HJ
    GRIFFIN, JL
    HITCHCOCK, CL
    CANCER, 1993, 71 (12) : 3947 - 3951
  • [5] Flow cytometric analysis of DNA ploidy in potentially malignant lesions (PML) of the oral mucosa
    Pentenero, M.
    Broccoletti, R.
    Brusa, M.
    Demurtas, A.
    Marsico, A.
    Conrotto, D.
    Navone, R.
    Gandolfo, S.
    ORAL ONCOLOGY, 2007, : 191 - 191
  • [6] Evaluation of Flow Cytometric Immunophenotyping and DNA Analysis for Detection of Malignant Cells in Serosal Cavity Fluids
    Sayed, Douaa M.
    El-Attar, Madiha M.
    Hussein, Aliaa A. R. Mohamed
    DIAGNOSTIC CYTOPATHOLOGY, 2009, 37 (07) : 498 - 504
  • [7] DNA flow cytometric analysis and numerical chromosome 9 aberrations detected by interphase cytogenetics in superficial bladder TCC
    Eleuteri, P
    Grollino, MG
    Pomponi, D
    Calugi, G
    Rocchi, M
    DeVita, R
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 1997, 41 : 161 - 162
  • [8] FLOW CYTOMETRIC DNA ANALYSIS IN GYNECOLOGICAL ONCOLOGY
    VANDAM, PA
    WATSON, JV
    LOWE, DG
    SHEPHERD, JH
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1992, 2 (02) : 57 - 65
  • [9] Flow cytometric DNA analysis of abnormal endometrium
    Sato, S
    Tanoguchi, K
    Tase, T
    Yajima, A
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 178 (02) : 199 - 202
  • [10] FLOW CYTOMETRIC ANALYSIS OF DNA PLOIDY IN LARGE CLEAVED CELL LYMPHOMAS
    AINE, R
    LEHTINEN, T
    LEHTINEN, M
    BLANCO, G
    APAJASARKKINEN, M
    LEINIKKI, P
    ALAVAIKKO, M
    HEMATOLOGICAL ONCOLOGY, 1990, 8 (06) : 339 - 346